Key regions: Brazil, India, Australia, United States, United Kingdom
The demand for Antiviral Drugs in Republic of the Congo has been steadily increasing over the past few years.
Customer preferences: The Republic of the Congo has a high prevalence of infectious diseases, including HIV/AIDS, tuberculosis, and malaria. As a result, there is a high demand for antiviral drugs that can effectively treat these diseases. Additionally, the country has a growing elderly population, which is also contributing to the increasing demand for antiviral drugs.
Trends in the market: The market for antiviral drugs in the Republic of the Congo is expected to grow at a steady pace in the coming years. This growth can be attributed to several factors, including the increasing prevalence of infectious diseases, the growing elderly population, and the improving healthcare infrastructure in the country. Additionally, the government of the Republic of the Congo has been taking steps to improve access to healthcare services, which is also expected to contribute to the growth of the antiviral drugs market.
Local special circumstances: The Republic of the Congo is a lower-middle-income country with a relatively small economy. As a result, the cost of healthcare is a major concern for many people in the country. However, the government has been taking steps to improve access to healthcare services, including increasing funding for healthcare and expanding healthcare infrastructure. Additionally, the country has a large number of non-governmental organizations and international aid agencies that are working to improve healthcare in the country.
Underlying macroeconomic factors: The Republic of the Congo has a relatively stable economy, with a GDP growth rate of around 2% in recent years. However, the country is heavily dependent on oil exports, which makes it vulnerable to fluctuations in global oil prices. Additionally, the country has a relatively high poverty rate, which limits the ability of many people to access healthcare services. Despite these challenges, the government of the Republic of the Congo has been working to improve healthcare services in the country, which is expected to contribute to the growth of the antiviral drugs market.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
